SAN FRANCISCO — Medicaid programs in Delaware, Maryland, New Jersey, and Pennsylvania denied nearly half of all claims in recent months for direct-acting antiviral hepatitis C drugs, according to an ...

​A bipartisan pair of House members are introducing legislation aimed at treating millions of Americans of a ...

NEW YORK (Reuters) - A hepatitis C treatment being developed by Vertex Pharmaceuticals Inc led to a 75 percent cure rate in a pivotal trial of previously untreated patients, the company said on ...

Simple math illustrates the challenge facing U.S. taxpayers, consumers and insurers following the launch late last year of two expensive new drugs to treat hepatitis C. If all 3 million people ...

(Reuters) - Achillion Pharmaceuticals Inc said the U.S. Food and Drug Administration decided not to lift a clinical hold it had placed on the firm's hepatitis C drug, sovaprevir, leaving an uncertain ...

Add Yahoo as a preferred source to see more of our stories on Google. Hepatitis C is an infection of the liver caused by the hepatitis C virus (HCV). Experts estimate that about 2.4 million people in ...

Sofosbuvir, Gilead Sciences' (GILD) oral hepatitis C drug was unanimously recommended for approval by an FDA advisory committee in October, thereby making it the front runner in the Hep C race. The ...

As many as 5 million Americans have hepatitis C, and new drugs can cure almost all of them. But patients worry they won't get these expensive... Medicare Won't Always Pay For Boomers' Pricey Hepatitis ...

Hepatitis E affects over 20 million people worldwide. It clears up without any consequences in most cases, but it can pose a risk to pregnant women and immunocompromised patients. There are no ...